You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

80 Results
Regimen
Cancer Type:
Hematologic, 
Myelodysplastic Syndrome (MDS)
Intent: Palliative
Funding:
ODB Limited Use
    lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to clinical criteria
May 2022
Regimen
Cancer Type:
Gynecologic, 
Ovary
Intent: Palliative
Funding:
New Drug Funding Program
    Liposomal Doxorubicin with Carboplatin - Platinum-Sensitive Recurrent Ovarian Fallopian Tube and Primary Peritoneal Cancer
Jun 2022
Regimen
Cancer Type:
Gastrointestinal, 
Colorectal, 
Small bowel and appendix
Intent: Palliative
Funding:
New Drug Funding Program
    Cetuximab with Irinotecan - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer
Jun 2022
Regimen
Cancer Type:
Gynecologic, 
Cervix
Intent: Palliative
Funding:
New Drug Funding Program
    Bevacizumab (Biosimilar) - Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
Apr 2022
Drug
Other Name(s): Neulasta® , Lapelga™ , Fulphila™ , Ziextenzo® , Nyvepria™
Dec 2022
Drug
Other Name(s): Cosmegen®
Jan 2022
Drug
Other Name(s): Perjeta®
Sep 2022
Drug
Other Name(s): Gazyva®
May 2022
Drug
Other Name(s): Polivy™
Dec 2022
Drug
Other Name(s): Mylotarg®
Jun 2022
Drug
Other Name(s): Oncaspar®
Dec 2022
Drug
Other Name(s): Femara®
May 2022

Pages